Wells Fargo’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-227,019
| Closed | -$6.5M | – | 6718 |
|
|
2018
Q4 | $6.5M | Sell |
227,019
-327,000
| -59% | -$9.29M | ﹤0.01% | 2193 |
|
|
2018
Q3 | $15.5M | Sell |
554,019
-6,910
| -1% | -$194K | ﹤0.01% | 1719 |
|
|
2018
Q2 | $15.7M | Buy |
560,929
+126,071
| +29% | +$3.38M | ﹤0.01% | 1690 |
|
|
2018
Q1 | $10.8M | Sell |
434,858
-225,473
| -34% | -$5.48M | ﹤0.01% | 1944 |
|
|
2017
Q4 | $16M | Sell |
660,331
-37,070
| -5% | -$977K | ﹤0.01% | 1628 |
|
|
2017
Q3 | $19.2M | Sell |
697,401
-23,553
| -3% | -$628K | 0.01% | 1449 |
|
|
2017
Q2 | $18.1M | Sell |
720,954
-339,500
| -32% | -$8.41M | 0.01% | 1454 |
|
|
2017
Q1 | $28.5M | Sell |
1,060,454
-181,946
| -15% | -$5.03M | 0.01% | 1180 |
|
|
2016
Q4 | $32.6M | Sell |
1,242,400
-21,048
| -2% | -$521K | 0.01% | 1058 |
|
|
2016
Q3 | $31.6M | Sell |
1,263,448
-77,204
| -6% | -$1.8M | 0.01% | 1005 |
|
|
2016
Q2 | $29.1M | Sell |
1,340,652
-362,346
| -21% | -$6.46M | 0.01% | 1055 |
|
|
2016
Q1 | $25.5M | Buy |
1,702,998
+252,691
| +17% | +$4.23M | 0.01% | 1128 |
|
|
2015
Q4 | $31.8M | Buy |
1,450,307
+88,286
| +6% | +$1.65M | 0.01% | 1020 |
|
|
2015
Q3 | $21.5M | Sell |
1,362,021
-52,782
| -4% | -$846K | 0.01% | 1257 |
|
|
2015
Q2 | $20.2M | Buy |
1,414,803
+553,829
| +64% | +$9.38M | 0.01% | 1367 |
|
|
2015
Q1 | $14.9M | Buy |
860,974
+123,142
| +17% | +$2.18M | 0.01% | 1544 |
|
|
2014
Q4 | $13.2M | Buy |
737,832
+4,056
| +0.6% | +$65.3K | 0.01% | 1594 |
|
|
2014
Q3 | $9.63M | Buy |
733,776
+17,589
| +2% | +$237K | ﹤0.01% | 1815 |
|
|
2014
Q2 | $10.3M | Sell |
716,187
-147,846
| -17% | -$1.93M | ﹤0.01% | 1799 |
|
|
2014
Q1 | $11M | Sell |
864,033
-674,325
| -44% | -$8.8M | ﹤0.01% | 1723 |
|
|
2013
Q4 | $15.4M | Sell |
1,538,358
-1,901,146
| -55% | -$21.6M | 0.01% | 1404 |
|
|
2013
Q3 | $45.3M | Sell |
3,439,504
-220,267
| -6% | -$2.89M | 0.02% | 740 |
|
|
2013
Q2 | $52.3M | Buy |
+3,659,771
| New | +$46M | 0.03% | 609 |
|
Other funds holding NXTM
Wells Fargo's NXTM Position: Q1 2019 in Review
Wells Fargo sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 227,019 shares — an estimated $6.5M sold.
Wells Fargo first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $52.3M in Q2 2013. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- Wells Fargo reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- Wells Fargo sold 227,019 NxStage Medical Inc. shares in Q1 2019, an estimated $6.5M.
- Wells Fargo first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
- Wells Fargo's NxStage Medical Inc. position peaked at $52.3M in Q2 2013.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on Wells Fargo's 13F filing for Q1 2019, filed 10 May 2019.